LGALS3 and systemic sclerosis: Galectin-3 (Gal-3), a fibrosis-related biomarker involved in macrophage activation and matrix remodeling, has been linked to faster lung function decline, radiographic fibrosis progression, and increased mortality in systemic sclerosis-associated pulmonary fibrosis [13].